Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Study of Propranolol Plus Sunitinib in First-line Treatment of Metastatic Renal Cell Carcinoma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03323710
Recruitment Status : Withdrawn (Poor patient recruitment.)
First Posted : October 27, 2017
Last Update Posted : January 9, 2019
Sponsor:
Information provided by (Responsible Party):
Paweł Chrom, Military Institute of Medicine, Poland

No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
Recruitment Status : Withdrawn
Estimated Primary Completion Date : December 2019
Estimated Study Completion Date : December 2019